ATTR amyloidosis is a life-threatening genetic disease that affects the heart, nerves and other organs.
$150 million upfront + up to $2.1 billion in milestone payments
Small-cap companies (that is, companies that are worth between $300 million and $2 billion) can be a risky investment, as smaller companies tend to have lower stock prices and thus are more
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
| Website: | www.prothena.com |
| Email: | info@prothena.com |
| Main Phone: | +353 12362500 |
| Address: | 77 Sir John Rogerson's Quay |
| Address 2: | Block C |
| City / Town: | Dublin |
| Country: | IE |
| Postal Code: | D02 T804 |
| Exchange: | NGS |
| CEO: | Gene G. Kinney |
| Employees: | 66 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
ATTR amyloidosis is a life-threatening genetic disease that affects the heart, nerves and other organs.
$150 million upfront + up to $2.1 billion in milestone payments
Small-cap companies (that is, companies that are worth between $300 million and $2 billion) can be a risky investment, as smaller companies tend to have lower stock prices and thus are more
Prothena Corporation (PRTA) , the drug discovery business that was spun-out of Elan Corp. (ELN) in December last year, reported its financial results for the second quarter ended June 30 after
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
